ZEMAX renewal of DBP licenses.
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $10,000 to $25,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 511210 Software Publishers
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring renewal of ZEMAX Design and Build Package (DBP) licenses, with an estimated solicitation release on June 1, 2027, and estimated award on September 1, 2027. This procurement falls under software publishers (NAICS 511210) and carries no set-aside.
The estimated award value ranges from $10,000 to $25,000. Inquiries should be directed to the FDA's Center for Devices and Radiological Health acquisitions team at cdhracquisitions@fda.hhs.gov.
Forecast text
BPID: 806- ZEMAX renewal of DBP licenses.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast